midmarket medtech, AI, time savings

Moog Medical used to spend seven minutes adding parts to every depot order. Across three sites — Salt Lake City, San Jose, and Vilnius — that manual yet important effort repeated constantly, reflecting the quiet cost of running an ERP built for a slower, steadier market. After Moog standardized onto an adaptive ERP platform, the same task dropped to under 30 seconds. Program Manager Jade Eldridge calls the result “mind-blowing.”

Noble Biomaterials tells a similar story from the other direction: its own leadership had stopped trusting the manufacturing data coming out of its patchwork of spreadsheets and disconnected systems. The fix wasn’t tighter oversight, it was one platform that unifies operations.

Neither company got here by chasing AI hype. Both companies solved a structural problem. Moreover, traditional ERPs tell you what already happened: they are systems of record. Midmarket medtech manufacturers are getting squeezed by inflation while adjusting to the FDA’s new QMSR where internal quality audit reports, supplier quality reports, and management records are now eligible for FDA review. They need something that acts, not just reports. The ChampionAI agentic layer for QAD Adaptive ERP further transforms QAD Adaptive ERP from a system of record into the system of action that’s needed now.

The companies pulling ahead aren’t the ones moving gingerly into implementing AI. They’re the ones who’ve already turned their ERP from a system of record into a system of action.

Want the full story? Get our latest whitepaper, “A New Era for Midmarket MedTech Manufacturing,” which includes case studies, information on how QMSR guidance is built natively into QAD Adaptive ERP, and how ChampionAI agents are organized.

Robyn Coward is the Life Sciences Director at QAD. With 21 years of experience in product commercialization, Robyn has spent the last 11 years focused on the global life sciences markets, particularly in the imaging, laboratory diagnostics, and healthcare IT segments. In her role, Robyn monitors and reports on the trends impacting QAD's life sciences customers. She is a member of several industry organizations including the Medical Device Contract Manufacturing Trends Group, Life Sciences Technology and Compliance Group, and the Healthcare Businesswomen's Association. Robyn also participates in various Biocom Institute activities, and enjoys residing in the San Francisco Bay area, one of the world's top hubs for biotechnology, pharmaceutical and medical device development and manufacturing, where she can see exciting and emerging healthcare innovations before they hit the market.

LEAVE A REPLY